Penumbra Inc (NYSE:PEN) EVP Lynn Rothman sold 6,000 shares of the stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $90.99, for a total transaction of $545,940.00. Following the transaction, the executive vice president now directly owns 159,519 shares of the company’s stock, valued at approximately $14,514,633.81. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Shares of Penumbra Inc (PEN) traded up $0.65 during midday trading on Thursday, hitting $90.10. 299,855 shares of the stock traded hands, compared to its average volume of 403,350. The stock has a market cap of $2,959.45, a PE ratio of -409.55, a price-to-earnings-growth ratio of 93.43 and a beta of 0.16. Penumbra Inc has a 52-week low of $67.95 and a 52-week high of $116.35.
Penumbra (NYSE:PEN) last announced its earnings results on Tuesday, November 7th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.07. The firm had revenue of $83.90 million for the quarter, compared to analysts’ expectations of $79.17 million. Penumbra had a negative net margin of 2.19% and a negative return on equity of 1.95%. The business’s revenue was up 24.9% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.04) EPS. equities research analysts predict that Penumbra Inc will post -0.15 earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Penumbra by 10.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,159 shares of the company’s stock valued at $102,000 after buying an additional 114 shares in the last quarter. Simplex Trading LLC raised its position in shares of Penumbra by 116.2% during the 4th quarter. Simplex Trading LLC now owns 1,911 shares of the company’s stock valued at $179,000 after buying an additional 1,027 shares in the last quarter. Teacher Retirement System of Texas purchased a new stake in shares of Penumbra during the 3rd quarter valued at about $214,000. Verition Fund Management LLC purchased a new stake in shares of Penumbra during the 2nd quarter valued at about $213,000. Finally, Ameritas Investment Partners Inc. raised its position in shares of Penumbra by 10.8% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,573 shares of the company’s stock valued at $226,000 after buying an additional 250 shares in the last quarter. Hedge funds and other institutional investors own 71.71% of the company’s stock.
Penumbra Company Profile
Penumbra, Inc is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.
Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.